GlaxoSmithKline | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
Alcon AG USD 6.07B 242M 2025-03
Almirall EUR 741.14M 47.91M 2024-12
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bayer EUR 34.83B 388M 2025-03
Biogen USD 7.63B 169.2M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Fresenius EUR 11.91B 462M 2025-03
Fresenius Medical Care EUR 7.96B 34.93M 2025-03
Galapagos EUR 3.47B 132.9M 2025-03
Genmab DKK 4.04B 23.82B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
GRIFOLS EUR 5.64B 87.54M 2025-03
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.45B 479M 2024-12
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Novo Nordisk 174.4B 20.76B 2025-03
Orion EUR 1.08B 67.7M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Philips EUR 8.67B 1.35B 2025-03
Recordati EUR 1.57B 310.28M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Smith & Nephew USD 4.42B 37M 2024-12
UCB EUR 4.79B 1.47B 2024-12



GlaxoSmithKline Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.